Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

Pharmaceutical companies in the diabetes market are all investing in tech to help doctors and patients manage the condition. That means companies such as Lilly, Novo Nordisk, Sanofi and ...

It plans to begin small-scale pilot studies "in selected countries through partnerships with existing diabetes management ecosystems." Lilly is trying to stay ahead of rivals Novo Nordisk and ...

Eli Lilly (NYSE: LLY) doesn’t really need much of an introduction. It has become a household name due to its obesity and ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...